| Característica |
Objectiu de la convocatòria
The European Rare Diseases Research Alliance (ERDERA) is excited to announce the upcoming launch of its Joint Transnational Call (JTC) for Proposals 2025. Set to officially open on December 10, 2024, this call will invite research teams from across Europe and beyond to submit collaborative projects focused on “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”.
|
Característiques principals
Projects should address at least two of the following:
Development of novel therapies in a pre-clinical setting.
Creation and validation of predictive and pharmacodynamic biomarkers.
Replication of pre-clinical findings to enhance reliability.
Pre-clinical proof-of-concept studies for therapy readiness.
Please note, certain approaches, including ATMP therapies and clinical trials, are excluded from this call. Detailed eligibility criteria are outlined in the Call Guidelines.
|
Lloc de presentació
El personal de l'HMRIB i PSMAR que necessiteu més informació adreceu-vos a:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@researchmar.net Ext.: 1670
Marta López: mlopez4@researchmar.net Ext.: 1576
|
Convocatòria (URL)
https://erdera.org/funding/
|
Requisits
Principal investigators (PIs) shall mandatory have PhD degree.
Principal Investigators (PI) can only participate in one project proposal per call.
Principal Investigators (PIs) belonging to an Accredited Health Research Institutes (IIS) could apply only from the IIS.
The Principal Investigator (PI) and all members of the research group must belong to the eligible institutions in the call.
Only one PI per beneficiary institution may be funded within the same proposal.
PIs that have an ongoing International Collaboration (PCIN) project of the same initiative and purpose that this call and that the project has an ending date after the 31st of December 2025 will not be able to apply for this call. This incompatibility will affect only to the PI. And this incompatibility will not apply in the case that the PI participate as coordinator in the new application or in the ongoing project.
For additional incompatibilities please check Líneas Estratégicas de Investigación en Salud_2025.
Excluded personnel as Principal Investigator (PI):
Those undergoing a postgraduate training in Health Specialization (MIR, EIR, FIR, QIR, BIR, PIR, RFIR)
Those undergoing research training (e.g. PhD students, or “Río Hortega” contracts).
Those undergoing postdoctoral training (e.g. “Sara Borrell” or “Juan de la Cierva” contracts).
Researchers contracted by a RICORs and platforms funded by ISCIII.
|
Dotació
Total 1,6 M€. 4-6 groups tentatively envisaged to be funded.
|
Durada
From 24 months to 36 months.
|
AVÍS IMPORTANT
Information webinar: December 17, 2024 | 14:00-16:00 CET | link: https://events.teams.microsoft.com/event/cdee57ea-49e4-4002-b4a8-dded8652806e@383ac401-a21d-426b-8072-5f74c36b7093
Call Launch: December 10, 2024
Pre-proposal Submission Deadline: February 13, 2025
Full Proposal Invitations: Early May 2025
Funding Decisions: December 2025
|